Rothschild Investment LLC Cuts Stake in DaVita Inc. (NYSE:DVA)

Rothschild Investment LLC lowered its stake in DaVita Inc. (NYSE:DVA) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,865 shares of the company’s stock after selling 176 shares during the period. Rothschild Investment LLC’s holdings in DaVita were worth $1,774,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Transcendent Capital Group LLC acquired a new stake in DaVita during the third quarter worth about $25,000. Blue Trust Inc. grew its holdings in shares of DaVita by 56.4% during the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after buying an additional 119 shares in the last quarter. Quarry LP purchased a new position in DaVita in the 3rd quarter worth approximately $60,000. Venturi Wealth Management LLC boosted its stake in DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after buying an additional 152 shares during the last quarter. Finally, Versant Capital Management Inc grew its holdings in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares during the period. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

DaVita Price Performance

DVA opened at $141.96 on Tuesday. The firm has a market cap of $11.36 billion, a price-to-earnings ratio of 13.22, a PEG ratio of 1.07 and a beta of 0.94. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The stock’s 50-day moving average price is $160.86 and its 200 day moving average price is $158.19. DaVita Inc. has a 12-month low of $124.42 and a 12-month high of $179.60.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, sell-side analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

Analyst Ratings Changes

DVA has been the topic of several analyst reports. Barclays lifted their price target on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. Cowen restated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $162.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.